Technical Analysis for GANX - Gain Therapeutics, Inc.

Grade Last Price % Change Price Change
C 4.36 1.63% 0.07
GANX closed up 1.63 percent on Monday, March 18, 2024, on 41 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 21
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.63%
Bollinger Band Squeeze Range Contraction 1.63%
Stochastic Reached Oversold Weakness 1.63%
BB Squeeze + Lower Band Touch Range Contraction 1.63%
Inside Day Range Contraction 1.63%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gain Therapeutics, Inc., a development stage biotechnology company, develops novel therapeutics to treat rare genetic and neurological disorders caused by protein misfolding in Switzerland and Spain. The company through its in-licensed proprietary Site-Directed Enzyme Enhancement Therapy platform, discovers novel allosteric sites on misfolded proteins, identifies proprietary binding sites, and restores protein folding. It has a research collaboration agreement with Sumitomo Dainippon Pharma Co., Ltd. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was founded in 2017 and is based in Bethesda, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Allosteric Regulation Sumitomo Group

Is GANX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.19
52 Week Low 2.0
Average Volume 172,979
200-Day Moving Average 3.68
50-Day Moving Average 4.20
20-Day Moving Average 4.55
10-Day Moving Average 4.54
Average True Range 0.30
RSI (14) 47.37
ADX 19.04
+DI 19.39
-DI 22.58
Chandelier Exit (Long, 3 ATRs) 4.28
Chandelier Exit (Short, 3 ATRs) 5.00
Upper Bollinger Bands 4.82
Lower Bollinger Band 4.27
Percent B (%b) 0.16
BandWidth 12.02
MACD Line 0.05
MACD Signal Line 0.12
MACD Histogram -0.0748
Fundamentals Value
Market Cap 70.63 Million
Num Shares 16.2 Million
EPS -1.81
Price-to-Earnings (P/E) Ratio -2.41
Price-to-Sales 1400.35
Price-to-Book 10.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.74
Resistance 3 (R3) 4.74 4.62 4.67
Resistance 2 (R2) 4.62 4.52 4.62 4.65
Resistance 1 (R1) 4.49 4.47 4.56 4.49 4.63
Pivot Point 4.37 4.37 4.40 4.37 4.37
Support 1 (S1) 4.24 4.27 4.31 4.24 4.09
Support 2 (S2) 4.12 4.22 4.12 4.07
Support 3 (S3) 3.99 4.12 4.05
Support 4 (S4) 3.99